Gryphon Financial Partners LLC Astrazeneca PLC Transaction History
Gryphon Financial Partners LLC
- $911 Million
- Q4 2025
A detailed history of Gryphon Financial Partners LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Gryphon Financial Partners LLC holds 6,612 shares of AZN stock, worth $591,112. This represents 0.06% of its overall portfolio holdings.
Number of Shares
6,612
Previous 5,472
20.83%
Holding current value
$591,112
Previous $419,000
41.05%
% of portfolio
0.06%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,545Shares Held
502MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...